Los Alamos, NM, United States of America

Timothy S Travers

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Timothy S. Travers in RNA Technology

Introduction

Timothy S. Travers is a notable inventor based in Los Alamos, New Mexico. He has made significant contributions to the field of biotechnology, particularly in the development of systems and methods for controlling host pathogen infections.

Latest Patents

Travers holds a patent for "Systems, methods and composition of using RNase III mutants to produce sRNA to control host pathogen infection." This invention encompasses systems, methods, and compositions for generating small RNA (sRNA) molecules using select RNase III mutants. A preferred embodiment of this invention includes the use of RNase III mutants to control a host pathogen through the production and diffusion of sRNA molecules, which may initiate an RNA interference (RNAi) pathway response directed at the pathogen. Additionally, the invention includes methods for DICER-independent generation of sRNA molecules using these mutants.

Career Highlights

Travers is currently associated with Pebble Labs Inc., where he continues to innovate in the field of RNA technology. His work focuses on developing solutions that can enhance agricultural practices and improve plant health by targeting pathogens effectively.

Collaborations

He has collaborated with notable colleagues such as Guohua Yin and Erick Scott Lebrun, contributing to advancements in their shared field of research.

Conclusion

Timothy S. Travers exemplifies the spirit of innovation in biotechnology through his groundbreaking work on RNA technology. His contributions have the potential to significantly impact the way we manage host pathogen infections in various applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…